More Time For NDI Guidance Comment: Health And Wellness Industry News Roundup
This article was originally published in The Rose Sheet
Executive Summary
Testing lapse prompts Sammy's Milk recall; Hain Celestial solves UK trade authority puzzle; scheduling kratom impact calculated; and more news in brief.
You may also be interested in...
DEA Takes Comments On Kratom, But Keeps Eye On Scheduling
DEA will accept comments through Dec. 1 on its proposal to move the active materials in kratom into Schedule I under CSA to avoid an imminent hazard to public safety.
Kratom Reprieve From Scheduling Requested By House Members
Members headed by Reps. Mark Pocan, D-WI, and Matt Salmon, R-AZ, say the proposal was made without allowing opportunity for comment by experts, supplement industry stakeholders and consumers.
Revised NDI Notification Draft Guidance Shrinks Divide Between FDA And Industry
More than four years after beginning to revise its widely criticized initial draft guidance on NDI notifications, FDA on Aug. 11 released a second draft. "I think it is reflective of a new effort by the agency to have a dialogue with the industry," says Steve Mister, president and CEO of the Council for Responsible Nutrition.